Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

$99.00

In Stock

Available Formats Price
ePub eBook $99.00
(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)
PDF eBook $99.00
(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

View other titles in the “ The Clinics: Internal Medicine” Series

View all Rheumatology titles

Author Information

    By John J Cush, Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas Clinical Professor of Internal Medicine, and Kathryn H. Dao

Customer Reviews

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • Hardcover
  • Reference
  • 240 Pages
  • Imprint: Saunders
  • ISBN: 978-1-4557-5065-8
  • Copyright: 2012